Liu Xueke, Su Guoyang, Wu Boyuan, and Liu Lianlong agreed to acquire 21% stake in Xiamen Aomu Trade Co., Ltd from Fujian Aonong Biological Technology Group Incorporation Limited for CNY 0.
Liu Xueke, Su Guoyang, Wu Boyuan, and Liu Lianlong agreed to acquire 21% stake in Xiamen Aomu Trade Co., Ltd from Fujian Aonong Biological Technology Group Incorporation Limited (SHSE:603363) for CNY 0 on January 12, 2018. Liu Xueke, Su Guoyang, Wu Boyuan, and Liu Lianlong will acquire 12% stake, 3% stake, 3% stake and 3% stake respectively. The transaction is subject to the Fujian Aonong Biological Technology shareholders’ approval. The transaction is approved by the Board of Fujian Aonong Biological Technology on January 12, 2018.